{"id":"doi:10.1038/s41582-022-00768-w","kind":"article","title":"Lecanemab trial in AD brings hope but requires greater clarity","authors":["Madhav Thambisetty","Robert J. Howard"],"author_count":2,"year":2023,"published":"2023-01-06","venue":"Nature Reviews Neurology","cited_by":51,"doi":"10.1038/s41582-022-00768-w","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1038/s41582-022-00768-w","archive_url":"https://space-kitty.com/papers/doi:10.1038/s41582-022-00768-w","updated":null,"pmid":"36609712","pmcid":null,"openalex_id":"W4313577358","pdf_url":"https://discovery.ucl.ac.uk/10169118/2/Howard_NRN_Lecanemab_MTRH.pdf","abstract":null,"abstract_license":null,"license":null,"is_open_access":true,"peer_reviewed":null,"categories":["Alzheimer's disease research and treatments"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"neurodegeneration","name":"Alzheimer's, Parkinson's & Neurodegeneration","domain_slug":"medicine"}],"cited_in_dossiers":[]}